MCK McKesson
- 543.300
- +3.360+0.62%
- 543.611
- +0.311+0.06%
McKesson News
McKesson (MCK) Rises But Trails Market: What Investors Should Know
Why McKesson (MCK) Is a Top Momentum Stock for the Long-Term
Dividend Roundup: MetLife, General Motors, Pfizer, Citigroup, and More
9 Stocks That Thrive When Interest Rates Are Higher -- Barrons.com
The prospect of elevated interest rates for longer has dented the broader stock market -- but history shows that is also the perfect environment for a select group of stocks to ga
9 Stocks That Thrive When Interest Rates Are Higher
Though economic stress could be on the way, a few groups of stocks can benefit.
McKinsey Faces Criminal Probe By DOJ For Opioid Consulting: Report
The U.S. Department of Justice is conducting a criminal investigation into the consulting firm McKinsey & Company for its role in advising major opioid manufacturers on increasing sales. The investiga
McKesson To Go Ex-Dividend On June 3rd, 2024 With 0.62 USD Dividend Per Share
April 25th - $McKesson(MCK.US)$ is trading ex-dividend on June 3rd, 2024. Shareholders of record on June 3rd, 2024 will receive 0.62 USD dividend per share on July 1st, 2024. The ex-dividend date
McKesson Keeps Quarterly Dividend at $0.62 Per Share; Payable July 1 to Shareholders of Record on June 3
11:30 AM EDT, 04/24/2024 (MT Newswires) -- McKesson Keeps Quarterly Dividend at $0.62 Per Share; Payable July 1 to Shareholders of Record on June 3 Price: 530.68, Change: -1.32, Percent Change: -0.25
Press Release: McKesson Corporation Declares Quarterly Dividend
McKesson Corporation Declares Quarterly Dividend IRVING, Texas--(BUSINESS WIRE)--April 24, 2024-- The Board of Directors of McKesson Corporation (NYSE:MCK) yesterday declared a regular dividend of 6
Barclays Reaffirms Their Buy Rating on McKesson (MCK)
Buy Rating Reaffirmed for McKesson Amid Strong Growth Prospects and OptumRx Contract Win
Goldman's Buybacks Basket: Buyback Growth Will Be 13% in 2024
Goldman Sachs analysts rebalanced their “buybacks basket” as 2024 buyback growth is forecasted to be 13%.
Buy Rating Affirmed: McKesson's Strategic Growth Bolstered by OptumRx Contract Win
Express News | Mckesson Corp Shares up About 1%
Express News | Evercore Says McKesson Wins OptumRX Contract Starting July
Why McKesson (MCK) Is a Top Value Stock for the Long-Term
Jim Cramer Is 'Willing To Let This Pharma Stock Catch Fire,' Advises Not To Sell McKesson
On CNBC's "Mad Money Lightning Round," Jim Cramer recommended holding ConocoPhillips (NYSE:COP)Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) is a "speculative play," Cramer said, "I am not against specul
Rite Aid Delays Major Bankruptcy Hearing to Account for Creditor Deals
14 Best 52-Week High Stocks To Invest In Now
Analysts Are Bullish on These Healthcare Stocks: Eli Lilly & Co (LLY), McKesson (MCK)
Analysis
Price Target
No Data
